Ticker
ATAICompany Name
ATAI LIFE SCIENCES NVSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -115.37M | $ -0.59 | 1 | 196.56M |
3/31/2025 | $ -144.77M | $ -0.82 | 1 | 176.27M |
12/31/2024 | $ -145.61M | $ -0.91 | 1 | 160.16M |
9/30/2024 | $ -124.54M | $ -0.78 | 1 | 160.62M |
6/30/2024 | $ -53.76M | $ -0.34 | 1 | 160.39M |
3/31/2024 | $ -29.43M | $ -0.19 | 1 | 158.89M |
12/31/2023 | $ -35.85M | $ -0.23 | 1 | 158.83M |
9/30/2023 | $ -58.12M | $ -0.37 | 1 | 155.79M |
6/30/2023 | $ -137.07M | $ -0.88 | 1 | 155.79M |
3/31/2023 | $ -141.5M | $ -0.91 | 1 | 155.79M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for ATAI LIFE SCIENCES NV is calculated as follows: EBITDA [ $ -169.51M ] / (Shares WA [ 93.02M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.82 ]
Minimum
Dec 31, 2020
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -10.86 |
max | $ 13.95 |
average | $ 2.01 |
median | $ 0.99 |
std | $ 4.26 |